Demyelinating diseases of the central nervous system (CNS) are among the most devastating and disabling disorders that may arise during infancy through to adolescence and may lead to severe handicap and even death. A common feature of demyelinated lesions is the differentiation block of oligodendrocyte precursors (OPC) at a pre-myelinating stage. However, the mechanistic basis for inhibition of myelin repair is not fully understood. Our recent work together with others identified a Wnt/beta-catenin effector TCF7l2 as a new essential transcription factor for OPC differentiation. Activation of canonical Wnt signaling by stabilization of the -catenin/TCF complex was shown to inhibit oligodendrocyte differentiation. We further demonstrated that disruption of the -catenin/TCF7l2 interaction by HDAC1/2 reversed Wnt signaling inhibition and promoted oligodendrocyte differentiation, suggesting that TCF7l2 functions as a signaling integrator to control the timing of oligodendrocyte differentiation. The long-term objective of the research proposed here is to develop compounds that modulate the Wnt/TCF7l2 signaling to promote oligodendrocyte myelination and remyelination. We reason that surrogate targets for modulation of the Wnt/TCF7l2 activity might well be embedded within the TCF7l2 modifiers or downstream genetic targets. To understand the mechanism by which TCF7l2 controls oligodendrocyte differentiation and myelination in vivo, we will utilize floxed TCF7l2 mice that carry a cre-mediated conditional knockout mutation of TCF7l2 to examine the effect of loss of TCF7l2 on oligodendrocyte differentiation and TCF7l2 function at different developmental stages during oligodendrocyte development. In addition, we will use a combination of transcriptome-profiling and chromatin immunoprecipitation-sequencing approaches to identify TCF7l2 target genes on a genome-wide scale. These studies will provide new insights into the genetic program that TCF7l2 controls to mediate its effect on oligodendrocyte differentiation and myelination in the mammalian CNS. These studies will be crucial to our understating of the molecular basis of CNS myelination and suggest potential targets to Wnt/TCF signaling for treating patients with myelinating diseases such as multiple sclerosis and periventricular leukomalacia - a precursor lesion of cerebral palsy occurred in premature infants.
The work proposed in research plans will provide better understanding of CNSmyelination and offer new therapeutic strategies to enhance myelin repair. It willnot only have scientific merits but also could be of practical value in treating adultpatients with myelinating disorders such as multiple sclerosis and periventricularcerebral palsy; the common cause of severe disability in infants.
|Dai, Zhong-Min; Sun, Shuhui; Wang, Chunyang et al. (2014) Stage-specific regulation of oligodendrocyte development by Wnt/?-catenin signaling. J Neurosci 34:8467-73|
|He, Xuelian; Zhang, Liguo; Chen, Ying et al. (2014) The G protein ? subunit G?s is a tumor suppressor in Sonic hedgehog-driven medulloblastoma. Nat Med 20:1035-42|
|Deng, Yaqi; Kim, BongWoo; He, Xuelian et al. (2014) Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP. Genesis 52:341-9|
|Shen, Yun-An A; Chen, Yan; Dao, Dang Q et al. (2014) Phosphorylation of LKB1/Par-4 establishes Schwann cell polarity to initiate and control myelin extent. Nat Commun 5:4991|
|Limpert, Allison S; Bai, Shujun; Narayan, Malathi et al. (2013) NF-ýýB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci 33:2388-97|
|Hennen, Stephanie; Wang, Haibo; Peters, Lucas et al. (2013) Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist. Sci Signal 6:ra93|
|Yang, Yan; Wang, Haibo; Zhang, Jie et al. (2013) Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation. Dev Biol 378:94-106|
|He, Li; Lu, Q Richard (2013) Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci Bull 29:129-43|
|Yu, Yang; Chen, Ying; Kim, Bongwoo et al. (2013) Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152:248-61|
|Weng, Qinjie; Chen, Ying; Wang, Haibo et al. (2012) Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 73:713-28|
Showing the most recent 10 out of 11 publications